Acutaas Chemicals stock analysis
Want to see IN:ACUTAAS full AI Analyst Report?
Acutaas Chemicals (ACUTAAS) Stock Price & Analysis
ACUTAAS Stock Chart & Stats
- Day’s Range
- INR 3,884.00 - INR 3,975.80
- 52-Week Range
- INR 1,571.20 - INR 4,132.75
- Previous Close
- INR 3,943.75
- Volume
- N/A
- Average Volume (3M)
- 46.06K
- Market Cap
- INR 322.89B
- Enterprise Value
- INR 267.04B
- Total Cash (Recent Filing)
- INR 2.41B
- Total Debt (Recent Filing)
- INR 83.49M
- Price to Earnings (P/E)
- 73.5
- Beta
- 0.99
- Next Earnings
- Feb 14, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 17, 2026
- Dividend Yield
- 0.06%
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability Growth
The sharp FY2026 acceleration in revenue and profitability indicates stronger earnings capacity and potential operating leverage. If maintained, this improvement can support reinvestment, strengthen the company’s competitive position, and provide a larger base for future growth over the next several quarters.
Low Recent Leverage
Very low recent leverage gives Acutaas Chemicals financial flexibility and limits the burden of interest or refinancing obligations. Combined with improved returns on equity, the balance sheet can support continued investment while leaving greater capacity to withstand operating volatility or pursue opportunities.
Improved Operating Cash Flow
The substantial FY2026 improvement in operating cash generation, including coverage of reported earnings, indicates better conversion of profitability into internal funding. This strengthens the company’s ability to support operations and investment, although continued monitoring is needed because free cash flow remains negative.
Bears Say
Persistently Negative Free Cash Flow
Negative free cash flow across the reported period means accounting profits have not translated into surplus cash after investment or working-capital needs. If persistent, this can constrain internally funded expansion, increase reliance on financing, and reduce flexibility during weaker operating periods.
Margin Volatility
The wide variation in margins shows that profitability has not been consistently stable across years. Even after the FY2026 improvement, a return toward weaker margins would reduce earnings visibility and could make future results more sensitive to product mix, operating conditions, or cost changes.
Historically Uneven Capital Structure
Although current leverage is very low, the FY2024 spike demonstrates that Acutaas Chemicals’ capital structure has not been uniformly stable over its full reported history. A recurrence could increase financing costs, reduce resilience, and limit the balance-sheet flexibility currently supporting the business.
Acutaas Chemicals News
ACUTAAS FAQ
What was Acutaas Chemicals’s price range in the past 12 months?
What is Acutaas Chemicals’s market cap?
When is Acutaas Chemicals’s upcoming earnings report date?
How were Acutaas Chemicals’s earnings last quarter?
Is Acutaas Chemicals overvalued?
Does Acutaas Chemicals pay dividends?
What is Acutaas Chemicals’s EPS estimate?
How many shares outstanding does Acutaas Chemicals have?
What happened to Acutaas Chemicals’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Acutaas Chemicals?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Acutaas Chemicals
Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceutical ingredients (APIs) for a wide range of medical treatments, including those for anti-retroviral applications, inflammation, psychiatric conditions, cancer, Parkinson's disease, depression, and blood coagulation disorders. The company also produces a diverse portfolio of specialty chemicals, serving various industries such as battery manufacturing, personal care, agricultural chemicals, protective coatings, electronics, and general industrial processes. Notable offerings in this category include photoresist chemicals for semiconductor fabrication and electrolyte additives essential for lithium battery cells. Additionally, Acutaas Chemicals provides commodity chemicals like parabens and methyl salicylate, among other fine chemicals, which find application in cosmetics, agricultural products, and various chemical sectors. The company was previously known as Ami Organics Limited, changing its name to Acutaas Chemicals Limited in May 2025.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Nareshkumar Ramjibhai Patel
- Employees
- 1,007
- Website
- www.acutaas.com
- Address
- Plot No. 440/4, 5 & 6, Surat, GU, 394230, IN
Acutaas Chemicals (ACUTAAS) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 5 | 4 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 10 | 0 | 2 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:AARTIINDAARTI Industries Ltd | ||
| IN:AETHERAether Industries Ltd. | ||
| IN:ANURASAnupam Rasayan India Ltd. | ||
| IN:ATULAtul Limited | ||
| IN:VINATIORGAVinati Organics Limited |








